RxDoctor Payments Data

Imran Zoberi, MD

Radiation Oncology · Saint Louis, MONPI 1710903034

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,371 of the $1,904 with a category attached, or 72.0%. Viewray Technologies Inc accounts for 72.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,371 and has fallen 86.6% since, to $184 in 2025.

$1,904in general payments, 2019–2025

Across 9 payments — averaging $211.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viewray Technologies Inc$1K
  • Siemens Medical Solutions USA, Inc.$281
  • Elekta, Inc.$130
  • Varian Medical Systems, Inc.$43
  • Amgen$31
  • Icotec Medical Inc.$25
  • plus $24 from 1 others
$26,760in research payments, 2019–2025

Across 3 payments — averaging $8920.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$27K

What the payments were for

  • Speaking & faculty fees$1,37172%
  • Food & beverage$53328%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,904 in reported general payments places this provider in the 65th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$167,129
Medicare patients
224
Services billed
1,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →